Epilepsy awareness days, weeks, and months: Their roles in the fight against epilepsy and the intersectoral global action plan on epilepsy and other neurological disorders.

Brain disorder Education Epilepsy awareness days Intersectoral Global Action Plan (IGAP) Neurological disorder Public awareness Seizures

Journal

Epilepsy & behavior : E&B
ISSN: 1525-5069
Titre abrégé: Epilepsy Behav
Pays: United States
ID NLM: 100892858

Informations de publication

Date de publication:
Nov 2023
Historique:
received: 18 04 2023
revised: 19 09 2023
accepted: 21 09 2023
medline: 4 12 2023
pubmed: 16 10 2023
entrez: 15 10 2023
Statut: ppublish

Résumé

This research sought to find out the epilepsy awareness days around the world and understand the nature and role of the days in the fight against epilepsy in relation to the Intersectoral Global Action Plan (IGAP) on epilepsy and other neurological disorders (2022-2031). We conducted a review of journal articles. The databases that we searched were ProQuest Central, EBSCOhost Academic Search Complete, EBSCO Medline, PubMed Central, Wiley Online, Directory of Open Access Journals (DOAJ), African Journals Online (AJOL), and Google Scholar. We limited our search to papers of relevance to our subject published between January 2000 and January 2023. We searched 'epilepsy awareness day, week, or month'. From the databases, 13 articles met our inclusion criteria. We augmented our results with a search on Google of articles about epilepsy awareness day, week, or month. We also searched directly on the websites of epilepsy organizations. We found that epilepsy awareness days fall into these categories: global awareness days (n = 2), awareness months (n = 4), regional awareness weeks (n = 5), and regional awareness days (n = 1). Our search for national awareness days (n = 7) was not comprehensive, and this could be an area for future research. The literature shows that epilepsy awareness days could play a role in (1) reducing knowledge and treatment gaps, (2) increasing participation, (3) unlocking resources, and (4) necessitating policy change and increasing networking. The major role of these dedicated days in the IGAP is to accelerate awareness and advocacy for policy change and improved interventions. Epilepsy awareness days are bringing stakeholders together already, and IGAP initiatives could tap into this achievement to accelerate awareness in a cost effective, contextual and collaborative manner. This could be achieved by adopting themes that relate more directly to the IGAP goals. Another important strategy is to motivate countries that do not have national epilepsy days or regions that do not have a regional awareness days, to consider doing one within the confines of resources.

Identifiants

pubmed: 37839248
pii: S1525-5050(23)00376-1
doi: 10.1016/j.yebeh.2023.109457
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

109457

Informations de copyright

Copyright © 2023 The Author(s). Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Rugare Mugumbate (R)

School of Health and Society, University of Wollongong, Australia; Department of Social Work & Community Development, University of Johannesburg, South Africa. Electronic address: rugare_mugumbate@uow.edu.au.

Raymond Klevor (R)

Neuroscience Research Laboratory of Marrakesh Medical School, Cadi Ayyad University, Marrakesh, Morocco; Department of Neurology, Mohammed VI University Medical Center, Marrakesh, Morocco.

Mauricio Olave Aguirre (MO)

Fundacion Centro Colambiano de Epilepsia y Emfermedades Neurologicas (FIRE), Colombia.

Gams Massi Daniel (GM)

Neurology Unit, Douala General Hospital, Faculty of Health Sciences, University of Buea, Cameroon.

Nasir Yaqoob (N)

National Institute of Cardiovascular Diseases, National Institute of Cardiovascular Diseases (NICVD), Karachi, Pakistan.

Keryma Acevedo (K)

Pontificia Universidad Católica de Chile Liga Chilena Contra la Epilepsia, Chile.

Enat Yewnetu (E)

Care Epilepsy Ethiopia, Ethiopia.

Chantal Kanyabutembo (C)

Epilepsy Alliance Africa (EAA), Rwanda.

Etedal Ahmed A Ibrahim (EAA)

Faculty of Medicine, Alneelain University. The National Centre for Neurological Science, Khartoum, Sudan.

Salim Boutadghart (S)

Neuroscience Research Laboratory of Marrakesh Medical School, Cadi Ayyad University, Marrakesh, Morocco; Department of Neurology, Mohammed VI University Medical Center, Marrakesh, Morocco.

Adam Janneh (A)

Foundation for Epilepsy and Stigma Support (FESS-GAM), Gambia.

Najib Kissani (N)

Neuroscience Research Laboratory of Marrakesh Medical School, Cadi Ayyad University, Marrakesh, Morocco; Department of Neurology, Mohammed VI University Medical Center, Marrakesh, Morocco.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH